Drive Your Discovery Research
Discovering and characterizing novel drug candidates for preclinical development depends on innovative and reliable science. Our unique combination of integrated, multidisciplinary drug discovery expertise and unparalleled scope of capabilities in targets, platforms, and therapeutic areas allow us to deliver depth and breadth in science with data and insight you can trust to progress your drug discovery programs.
Discovery Services:
• Integrated Drug Discovery
• Chemistry
• Screening & Profiling Assays
• DMPK/ADME
• Pharmacology Studies
• Discovery Facilities
Discovery Services and Facilities
Discovering and characterizing novel drugs depends on innovative and reliable science. Our multidisciplinary drug discovery expertise and scope of capabilities allow us to deliver data and insight clients can trust to progress their drug discovery programs. Browse Our Services
Track Record of Candidates
Check out our preclinical candidate delivery and patent track record by therapeutic area. Will our next discovery be yours?
Resource Links
Need more information on a specific therapeutic area or technology? Check out these resources…
Oncology
• Oncology Analysis Methods & Endpoints
• Oncology Models
• Oncology Assays
• Oncology & Immuno-Oncology Studies
Neuroscience
• Neuroscience Methods & Endpoints
• Neuroscience Studies
Platform Technologies
• Hit Finding eGuide for Hit Identification
• Antibody Library Screening for Antibody Discovery
• Screening and Profiling Assays
Immunology/Inflammation
• Inflammation & Autoimmune Disease Studies
• In Vitro Immunology
Other
• Cardiovascular/Metabolic Disease Studies
• Musculoskeletal Disease Studies
• Ocular Disease Studies
Newsletters
Catch up on our latest news collections…
• Q2 2020: New Regulations for COVID-19 Vaccine Development
• Q1 2020: Expanding Digital Resources To Support You
• Q4 2019: See How This Little Girl Changed Drug Development Forever
• Q3 2019: A Collaborative Breakthrough for Cardiovascular Patients
Quarterly Newsletter
Catch up on our latest news collections…
New Regulations for COVID-19 Vaccine Development
International Coalition of Medicines Regulatory Authorities held a meeting for development of a vaccine to fight COVID-19. Their insight can be vital in how you proceed with your program.
Fail Fast, Fail Early
Using pharmacodynamic efficacy biomarkers in earlier stages of testing can lead to lower drug development costs and improve your drug candidate’s chances of progressing beyond Phase II.
Enter a New Era of CNS Drug Discovery
The complexity of the brain and high attrition rates can make neuroscience drug discovery a daunting process, but you don’t have to do it alone.
Upcoming Webinars
Oncologists: What Antibodies Can Do for You | July 13, 2020
Human Dose Predictions in Early Drug Discovery | July 21, 2020
A Molecular Journey to Investigate Memory Enhancement | July 22, 2020
On Demand Webinars
A New Translational In Vivo Tool for Oncology Drug Discovery: Zebrafish Tumor Xenograft Model
Bioinformatics: Mining Big Data to Discover Precision Oncology Therapies